REDEEMABLE CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT AMONG DICERNA PHARMACEUTICALS, INC. AND THE INVESTORS NAMED HEREIN DATED AS OF MARCH 30, 2017Redeemable Convertible Preferred Stock Purchase Agreement • March 30th, 2017 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 30th, 2017 Company Industry JurisdictionThis REDEEMABLE CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into this 30th day of March, 2017 by and among Dicerna Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the Persons named on the signature pages hereto under the heading “Investors” (the “Investors”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 9 hereof.